Trade In Mexico
Trade In Mexico
Send Message
Trade In Mexico
Stop FollowingTrade In Mexico
View as an RSS Feed
COMMENTS STATS
268 Comments
318 Likes

Why BioMarin, Catalyst Pharmaceutical Partners And Vertex Are Expected To Outperform [View article]
http://bit.ly/184KaYO
This Summer Slowdown Will Be Different Than The Previous 3 [View article]
Lot78 Inc: Why This $240 Million Company Could Drop By 75% Or More [View article]
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential [View article]
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential [View article]
http://yhoo.it/14chttx
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential [View article]
PTN has about $33 million in cash on the balance sheet, and and almost no debt ($31,000). Plus it has the $145 million agreement with AZN and the book value is 81 cents per share which is made up of cash. The FSD data has been positive and so the obesity drug development would just be a real bonus. I like that PTN stock has built a nice bottom/base around current levels and with such a strong balance sheet and the AZN agreement, seems to have limited downside with major upside as indicated by Roth Capital's $6 price target.
balance sheet info:
http://yhoo.it/YSy1PZ
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential [View article]
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential [View article]
As for point 2) yes it is the same but for different indications.
http://bit.ly/17XDJab
Hope it does well for you!
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential [View article]
These Obesity Stock Plays Could Offer 'Blockbuster' Drug Potential [View article]
These 4 'High-Potential' Biotech Stocks Could Outperform In 2013 [View article]
These 4 'High-Potential' Biotech Stocks Could Outperform In 2013 [View article]
These 4 'High-Potential' Biotech Stocks Could Outperform In 2013 [View article]
These 4 Cheap Commodity Stocks Could Be Poised For A Strong Rebound [View article]
Why These Below $6 Tech Stocks Are Now Too Cheap To Ignore [View article]